TScan Therapeutics
NASDAQ: TCRX
$0.39
as on
TScan Therapeutics Stock Performance
as on September 3, 2026 at 6:59 am IST
Day's Low
Day's High
$0.36$0.57
7.69%
Downside
46.15%
Upside
52 Week's Low
52 Week's High
$0.66$2.57-68.10%
Downside
558.97%
Upside
TScan Therapeutics share price movements today
- Previous Close
- $0.67
- Open
- $0.55
- Volume
- 8.0M
- Market Cap
- $49.5M
- Day's Low - High
- $0.36 - $0.57
- 52 Week Low - High
- $0.66 - $2.57
TScan Therapeutics Historical Returns
- 1 Month Return
- -10.32 %
- 3 Month Return
- -32.01 %
- 1 Year Return
- -61.93 %
- 3 Year Return
- -72.91 %
- 5 Year Return
- -92.57 %
TScan Therapeutics Stock Fundamentals & Key Indicators
Check TScan Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$49.5M
EPS (TTM)
-0.8725
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-115.7M
Revenue (TTM)
7.1M
Profit Margin
0.00%
Return On Equity TTM
-95.81%
TScan Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of TScan Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $49.5M | -92.57% | NA | 0.00% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $137.9B | 174.9% | 31.92 | 86.04% | NA | |
| BUY | $61.6B | -61.21% | -7.98 | -12.57% | NA | |
| BUY | $82.3B | 21.91% | 19.9 | 84.86% | 0.44% |
Stock Returns calculator for TScan Therapeutics Stock including INR - Dollar returns
The TScan Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
TScan Therapeutics investment value today
Current value as on today
₹24,049
Returns
Returns from TScan Therapeutics Stock
Dollar Impact
₹1,763 (+1.76%)
Analyst Recommendation on TScan Therapeutics Stock
Based on 6 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for TScan Therapeutics. Average target price of $6
TScan Therapeutics Share Price Target
Get share price movements and forecasts by analysts on TScan Therapeutics.
What analysts predicted
93.5%UPSIDE
Target Price
$6
Current Price
$0.39
Analyzed by
6 Analysts
Target
$6.00
TScan Therapeutics target price $6, a slight upside of 93.5% compared to current price of $0.39. According to 6 analysts rating.
Indian Investors' Interest in TScan Therapeutics Stock
Search interest for TScan Therapeutics Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:39% versus previous 30 day period
TScan Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
TScan Therapeutics Annual Profit & Loss
All numbers in Millions USD
TScan Therapeutics Quarterly Cash Flow
All numbers in Millions USD
TScan Therapeutics Annual Cash Flow
All numbers in Millions USD
TScan Therapeutics News & Key Events
Today's Timeline - 02 September
Wed, 05:29 PM
-TScan Therapeutics announces strategic reorganization, focusing on solid tumors and reducing workforce by 75% amid financial pressures.
Insights on TScan Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 982.0K → 1.05M (in $), with an average increase of 6.6% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 37.1% return, outperforming this stock by 110.0%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 537.7% return, outperforming this stock by 599.6%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, -22.97M → -30.35M (in $), with an average decrease of 15.3% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, TCRX stock has moved down by -14.3%
About TScan Therapeutics
| Organisation | TScan Therapeutics |
| Headquarters | 830 Winter Street, Waltham, MA, United States, 02451 |
| Industry | Biotechnology |
| CEO | Dr. Gavin MacBeath Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of TScan Therapeutics
Name | Title |
|---|---|
Dr. Gavin MacBeath Ph.D. | CEO & Director |
Mr. Jason A. Amello CPA | CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer |
Dr. Chrystal U. Louis M.D., M.P.H. | Chief Medical Officer |
Dr. Stephen J. Elledge Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
Mr. Tomasz Kula Ph.D. | Co-Founder & Member of Advisory Board |
Dr. Zoran Zdraveski J.D., Ph.D. | Chief Legal & Strategy Officer and Company Secretary |
Ms. Ann Hargraves | Chief Human Resources Officer |
Dr. Shrikanta Chattopadhyay M.D. | Senior VP & Head of Translational Medicine |
FAQs
What is TScan Therapeutics share price today?
TScan Therapeutics share price today is $0.39 as on at the close of the market. TScan Therapeutics share today touched a day high of $0.57 and a low of $0.36.
What is the 52 week high and 52 week low for TScan Therapeutics share?
TScan Therapeutics share touched a 52 week high of $2.57 on and a 52 week low of $0.66 on . TScan Therapeutics stock price today i.e. is closed at $0.39,which is 84.82% down from its 52 week high and -40.51% up from its 52 week low.
What is TScan Therapeutics's market capitalisation today?
TScan Therapeutics market capitalisation is $0.00T as on .
How to invest in TScan Therapeutics Stock (TCRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for TScan Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in TScan Therapeutics Shares that will get you 3.8462 shares as per TScan Therapeutics share price of $0.39 per share as on September 3, 2026 at 1:29 am IST.
What is the minimum amount required to buy TScan Therapeutics Stock (TCRX) from India?
Indian investors can start investing in TScan Therapeutics (TCRX) shares with as little as ₹94.96 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in TScan Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on TScan Therapeutics share’s latest price of $0.39 as on September 3, 2026 at 1:29 am IST, you will get 25.6410 shares of TScan Therapeutics. Learn more about
fractional shares .
What are the returns that TScan Therapeutics has given to Indian investors in the last 5 years?
TScan Therapeutics stock has given -92.57% share price returns and 30.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?